Mallinckrodt PLC
MNK
Delayed Nyse - 09/26 04:21:08 pm
35.099USD
-0.43%
Prev.35.2500
Open35.1700
High35.4600
Low35.0000
Volume215 945
Last news
Financials
Sales 2017 3 287 M
EBIT 2017 1 223 M
R. net 2017 493 M
Debt 2017 5 070 M
Rend. 2017 -
P/E ratio 2017 8,31
P/E ratio 2018 9,67
EV / Sales 2017 2,58x
EV / Sales 2018 2,55x
Capitalization 3 426 M
Company
Mallinckrodt Plc operates as a global specialty pharmaceuticals company.It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents.It operates through the following segments: Specialty Brands, Specialty Generics, and...
Sector :
Specialty & Advanced Pharmaceuticals
Calendar :
2017-10-04 Investor Meeting
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance36,841,247,4
Spread/Res.-4,6%-15%-26%
Spread/Supp.4,0%4,0%2,4%
Support33,833,834,3